MedTrace Logo

Coagulopathy and SIRS During ECC in Intensive Care

NCT02352805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2021-04-29

No results posted yet for this study

Summary

This observational clinical study investigates cellular and plasmatic activation markers as well as proteins involved in coagulation and inflammation in patients being connected to different extracorporeal circulation (ECC) and circulatory support devices under intensive care conditions.

Conditions

  • Disorder of Circulatory System

Interventions

DEVICE

ECLS/ECC

Extracorporeal circulation and mechanical circulatory support for heart or lung or renal failure during intensive care therapy or cardiac surgery

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Helene Häberle, MD · University of Tübingen, Dept. of Anesthesiology and Intensive Care Medicine, Germany

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-30
Primary Completion
2020-06-10
Completion
2020-11-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02352805 on ClinicalTrials.gov